Current Perspective on Nasal Delivery Systems for Chronic Rhinosinusitis
- Authors
- Tai, Junhu; Lee, Kijeong; Kim, Tae Hoon
- Issue Date
- 2월-2021
- Publisher
- MDPI
- Keywords
- topical treatment; drug delivery; chronic rhinosinusitis; fluid dynamics; upper respiratory diseases
- Citation
- PHARMACEUTICS, v.13, no.2, pp.1 - 21
- Indexed
- SCIE
SCOPUS
- Journal Title
- PHARMACEUTICS
- Volume
- 13
- Number
- 2
- Start Page
- 1
- End Page
- 21
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/49657
- DOI
- 10.3390/pharmaceutics13020246
- ISSN
- 1999-4923
- Abstract
- Chronic rhinosinusitis is an upper respiratory disease during which topical drug treatment via the nasal cavity is the most actively utilized therapeutic strategy. In addition to steroids, antibiotics, and antifungal agents, which are widely used in clinical practice, research on novel topical agents to improve the bacterial biofilm or mucociliary clearance remains ongoing. Moreover, owing to the complex structure of the nasal cavity, the effects of nasal drug delivery vary depending on factors related to delivery fluid dynamics, including device, volume, and compounds. In this article, we review methods and compounds that have been applied to chronic rhinosinusitis management and introduce recent advances and future perspectives in nasal drug delivery for upper respiratory diseases.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Biomedical Sciences > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.